AR
NVRO

Advisory Research’s NEVRO CORP. NVRO Stock Holding History

Advisory Research’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,950
Closed -$592K – 483
2017
Q2 		$592K Sell
7,950
-97,688
-92% -$7.83M 0.01% 352
2017
Q1 		$9.9M Buy
105,638
+17,122
+19% +$1.55M 0.15% 109
2016
Q4 		$6.43M Buy
+88,516
New +$7.58M 0.1% 114

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Advisory Research's NVRO Position: Q3 2017 in Review

Advisory Research sold out of NEVRO CORP. (NVRO) in Q3 2017, closing a stake of 7,950 shares — an estimated $592K sold.

Advisory Research first reported a position in NVRO in Q4 2016 and held it in 3 quarters. The position peaked at $9.9M in Q1 2017. 183 funds tracked by Wall St. Rank hold NVRO as of Q3 2017.

  • Advisory Research reported no remaining NEVRO CORP. position as of Q3 2017 after selling out during the quarter.
  • Advisory Research sold 7,950 NEVRO CORP. shares in Q3 2017, an estimated $592K.
  • Advisory Research first reported a position in NEVRO CORP. in Q4 2016 and held it in 3 quarters.
  • Advisory Research's NEVRO CORP. position peaked at $9.9M in Q1 2017.
  • 183 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2017.

Based on Advisory Research's 13F filing for Q3 2017, filed 14 Nov 2017.